Vaughan Nelson Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Vaughan Nelson Investment Management's LLY Position: Q2 2026 in Review
Vaughan Nelson Investment Management reduced its Eli Lilly (LLY) stake by 4.9% in Q2 2026, selling an estimated $12.7M and leaving 238,515 shares worth $286M. The position accounts for 2.53% of the portfolio, ranked #2.
Vaughan Nelson Investment Management first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Vaughan Nelson Investment Management held 238,515 shares of Eli Lilly worth $286M as of Q2 2026.
- Vaughan Nelson Investment Management sold 12,403 Eli Lilly shares in Q2 2026, an estimated $12.7M.
- Eli Lilly made up 2.53% of Vaughan Nelson Investment Management's portfolio in Q2 2026, its #2 holding.
- Vaughan Nelson Investment Management first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Vaughan Nelson Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.